GlaxoSmithKline, CureVac, and more Companies Making Stock Price Movements
Now that the pandemic is going away, the stock markets are regaining pre-pandemic statuses. Several companies have been making huge price movements no matter they are trending higher or trending lower.
GlaxoSmithKline has appeared as one of the high-performing drug-making companies that are listed on the US Stock Exchange. The drugmaker has reported that its share prices have experienced a 3.1% increase, which was recorded in the premarket trading. GlaxoSmithKline has revealed that the reason behind its stock price growth is the surge in sales. The consumers have been acquiring the products for the company at a really high rate. The company has revealed that in the running year, it has generated $54 billion worth of product sales. As a result of its surging performance, a private equity firm has expressed its interest in acquiring the drugmaker.
CureVac is another drugmaker that has reportedly faced a downtrend in terms of its market performance. The data from the stock market report shows that its share prices have experienced a huge plunge. The stats show that its prices have experienced a 15.5% slump that has been recorded in the premarket trading. The reason behind a sharp loss in the share prices of the drugmaker is the announcement that it has made recently.
The company has announced that it is going to discontinue the production of its vaccine candidate, which is its most advanced vaccine for COVID-19. This is because of the decision that has been made by the European Medicines Agency. It has revealed that the approval process for the COVID-19 vaccine will not be fast-tracked at all.
Airbnb is the next company on the list that has experienced a rise in share prices. The data shows that in the premarket trading, its share prices have experienced a 2.4% increase. This is because Airbnb’s stock status has recently been upgraded by analysts from Cowen. According to reports, the stock status of the company has been upgraded to “outperform”. Previously, the stock status of the company was set to “market perform”. The analysts from Cowen have stated that the year 2022 is going to be really positive for the bookings for air travel. It has been predicted by the analysts that by 2022, the booking growth would be on an entirely new level.
Signet Jewelers have reportedly experienced a 3.1% rise in their share prices in the premarket trading. Signet Jewelers is one of the most prominent retailers for jewelry. The company has announced that it is going to proceed with acquiring Diamonds Direct, which is its rival company. The company has revealed that the deal between the companies would stand out to be worth $490 million.